NDC 85237-2945-01 - Tylenol PM Extra Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-2945
- Requested NDC
- 85237-2945-01
- Package NDCs from labels
- 85237-2945-0, 85237-2945-1, 85237-2945-2, 85237-2945-7, 85237-2945-3, 85237-2945-4, 85237-2945-6, 85237-2945-01
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-07-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tylenol PM Extra Strength - Select Consumer Group | Select Consumer Group | 2026-07-04 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin 81 mg Low dose | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | bfb9af64-3195-44bf-bcf3-6b36b40d3cc7 | 2024-06-13 | Warnings | M013 |
| 8 Hour Arthritis Pain | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | b098ebf6-a76d-4550-b5c4-fdc3b4ceb9a8 | 2024-06-13 | Warnings | 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 1ac7ed71-5afe-d09c-e063-6294a90a3b88 | 2024-06-13 | Warnings | M013 362O9ITL9D |
| Pain Relief PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 3ce5bbf2-d449-464e-abeb-5c26866d1ab5 | 2024-06-13 | Warnings | M013 1092189 TC2D6JAD40 362O9ITL9D |
| Aspirin | ASPIRIN | AAA Pharmaceutical, Inc. | 609948d6-0f20-4d0c-adc0-6ae72a4f2b7a | 2024-06-13 | Warnings | M013 |
| Aspirin | ASPIRIN | AAA Pharmaceutical, Inc. | 3f73a359-59d7-47bb-872e-914b0db719af | 2024-06-13 | Warnings | M013 |
| 8HR Muscle Aches and Pain | ACETAMINOPHEN | AAA Pharmaceutical, Inc. | 15abb899-e301-40e6-e063-6294a90a4bac | 2024-06-13 | Warnings | 362O9ITL9D |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | DISCOUNT DRUG MART | 0ac12ced-70b3-7bbe-e063-6394a90aad52 | 2024-06-13 | Warnings | 362O9ITL9D |
| 8HR Muscle Aches and Pain | ACETAMINOPHEN | FSA STORE INC. | 13268603-0080-22cf-e063-6394a90a7db4 | 2024-06-13 | Warnings | 362O9ITL9D |
| Protectif Untinted | ZINC OXIDE AND TITANIUM DIOXIDE | Derma Research Group Inc. | 1acd3f09-87f2-75e4-e063-6394a90a0cd9 | 2024-06-13 | Warnings | 15FIX9V2JP |
| topcare infants pain and fever | ACETAMINOPHEN | Topco Associates LLC | f1e940ef-3cf0-4a5c-8158-156d0e5a680d | 2024-06-13 | Warnings | M013 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Trifecta Pharmaceuticals USA LLC | 026bf664-d598-73de-e063-6394a90a9206 | 2024-06-12 | Warnings | M013 362O9ITL9D |
| Regular Strength Pain Relief | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 7c73fc75-af9b-177c-e053-2a91aa0ada56 | 2024-06-12 | Warnings | M013 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | NuCare Pharmaceuticals,Inc. | 7d69403e-90d0-7a80-e053-2a91aa0a5552 | 2024-06-12 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Low Dose Aspirin | ASPIRIN | Topco Associates | 4a6a1dbb-c813-42fd-9bb8-497aec339466 | 2024-06-11 | Warnings | M013 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | NuCare Pharmaceuticals,Inc. | 6f2ce909-6356-1c2c-e053-2a91aa0a0135 | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | The Kroger Co. | fa234639-caf8-4c52-9ffe-f1c0c057ee5b | 2024-06-10 | Warnings | M013 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | The Kroger Co. | bc18590d-6481-4efe-8a3b-974f7543b754 | 2024-06-10 | Warnings | M013 362O9ITL9D |
| ASPIRIN | ASPIRIN | H-E-B | 085b35db-62e4-38db-e063-6394a90a9763 | 2024-06-07 | Warnings | M013 |
| Nighttime Sleep Aid | DIPHENHYDRAMINE HYDROCHLORIDE | TARGET CORPORATION | 135d2212-2122-b7a1-e063-6294a90aa5f5 | 2024-06-07 | Warnings | TC2D6JAD40 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.